Back

Left atrial strain tracks abnormal ventricular mechanics in Fabry disease

Cheepvasarach, C.; Gribble, M.; Vijapurapu, R.; Nordin, S.; Ugander, M.; Steeds, R.; Tchan, M.; Moon James C, M.; Pathan, F.; Kozor, R.

2025-03-03 cardiovascular medicine
10.1101/2025.03.02.25323185
Show abstract

BackgroundsFabry disease (FD) is an X-linked lysosomal disorder with ventricular myocardial involvement that drives morbidity and mortality. Early diagnosis of cardiac involvement can be difficult. This study explored whether abnormal left atrial (LA) strain by cardiovascular magnetic resonance (CMR) may be an early sign of ventricular involvement in FD. MethodsA multicenter, multinational cohort of FD patients was assembled with images centralized for corelab analysis. Adult gene-positive FD patients and healthy volunteers (HV) underwent CMR. LA strain analyses included manually contouring the LA in end-diastole and end-systole to calculate LA volumes and ejection fraction, then semi-automatic analysis for LA reservoir strain. ResultsThere were n=214 FD patients (mean age 45{+/-}15 years, 39% males) and n=76 HV (49{+/-}15 years, 53% males). CMR results in FD: LVEF 73% (IQR=9), LV mass indexed (LVMi) 89{+/-}39g/m2, 99 (46%) had left ventricular hypertrophy (LVH), 36% had late gadolinium enhancement. In FD, LA strain correlated with LVMi (r=-0.52, p<0.01), LV global longitudinal strain (GLS) (r=-0.61,p<0.01), and native myocardial T1 (r=0.34, p<0.01). FD had abnormal LA strain in overt disease (LVH +ve) compared to HVs (p<0.01). LVH-negative FD did not differ in LA strain compared with HV (p>0.5). FD with low T1+LVH-negative did not differ in LA strain compared with normal T1/LVH-negative FD or HV (p>0.3). ConclusionsLA strain is abnormal in FD with LVH (overt disease) and correlates with LVMi, native T1, and GLS. LA strain is normal in FD with early disease (LVH negative+low T1) and normal in FD with no myocardial disease (LVH negative + normal T1). These findings indicate that LA strain is a consequence of abnormal LV mechanics such as LVH and abnormal GLS, rather than isolated myocardial sphingolipid deposition. KEY MESSAGESO_ST_ABSWhat is already known on this topicC_ST_ABSFabry disease is an X-linked lysosomal disorder with potential cardiac complications. Progressive ventricular myocardial involvement drives morbidity and mortality and can be detectable through advanced imaging techniques like cardiovascular magnetic resonance. Early diagnosis of cardiac involvement can be difficult. What this study addsLA strain is abnormal in overt Fabry disease with left ventricular hypertrophy (LVH) and correlates with left ventricular mass, native T1, and global longitudinal strain (GLS). LA strain is normal in Fabry with early disease (LVH negative+low T1) and normal in FD with no myocardial disease (LVH negative + normal T1). These findings indicate that LA strain is a consequence of abnormal LV mechanics such as LVH and abnormal GLS, rather than isolated myocardial sphingolipid deposition. How this study might affect researchThere is a need to identify markers of early cardiac involvement in Fabry disease.

Matching journals

1
Circulation: Genomic and Precision Medicine
Ovid Technologies (Wolters Kluwer Health) · based on 30 published papers
Top 0.5%
42× avg
2
European Heart Journal
Oxford University Press (OUP) · based on 14 published papers
Top 0.1%
47× avg
3
Journal of the American College of Cardiology
Elsevier BV · based on 11 published papers
#1
80× avg
4
Frontiers in Cardiovascular Medicine
Frontiers Media SA · based on 33 published papers
Top 2%
15× avg
5
Circulation
Ovid Technologies (Wolters Kluwer Health) · based on 37 published papers
Top 2%
15× avg
6
Circulation: Heart Failure
Ovid Technologies (Wolters Kluwer Health) · based on 11 published papers
Top 0.5%
42× avg
7
Atherosclerosis
Elsevier BV · based on 16 published papers
Top 0.9%
22× avg
8
The American Journal of Cardiology
Elsevier BV · based on 15 published papers
Top 2%
18× avg
9
PLOS ONE
Public Library of Science (PLoS) · based on 1737 published papers
Top 78%
2.9%
10
BMJ Open
BMJ · based on 553 published papers
Top 30%
2.9%
11
EBioMedicine
Elsevier BV · based on 21 published papers
#1
24× avg
12
Arteriosclerosis, Thrombosis, and Vascular Biology
Ovid Technologies (Wolters Kluwer Health) · based on 11 published papers
Top 0.8%
26× avg
13
Journal of the American Heart Association
Ovid Technologies (Wolters Kluwer Health) · based on 92 published papers
Top 8%
3.1× avg
14
Open Heart
BMJ · based on 18 published papers
Top 3%
10× avg
15
Journal of Internal Medicine
Wiley · based on 12 published papers
#1
32× avg
16
International Journal of Cardiology
Elsevier BV · based on 13 published papers
Top 2%
18× avg
17
Genome Medicine
Springer Science and Business Media LLC · based on 56 published papers
Top 4%
5.1× avg
18
Heart
BMJ · based on 10 published papers
Top 2%
19× avg
19
Biomedicines
MDPI AG · based on 21 published papers
Top 1%
13× avg
20
Scientific Reports
Springer Science and Business Media LLC · based on 701 published papers
Top 71%
1.6%
21
Frontiers in Neurology
Frontiers Media SA · based on 74 published papers
Top 8%
2.5× avg
22
Orphanet Journal of Rare Diseases
Springer Science and Business Media LLC · based on 15 published papers
Top 1%
16× avg
23
European Heart Journal - Digital Health
Oxford University Press (OUP) · based on 15 published papers
Top 2%
8.7× avg
24
Heart Rhythm
Elsevier BV · based on 16 published papers
Top 3%
5.5× avg
25
European Journal of Preventive Cardiology
Oxford University Press (OUP) · based on 12 published papers
Top 2%
12× avg
26
BMC Cardiovascular Disorders
Springer Science and Business Media LLC · based on 11 published papers
Top 3%
8.3× avg
27
Acta Neuropathologica Communications
Springer Science and Business Media LLC · based on 10 published papers
Top 0.7%
25× avg
28
EMBO Molecular Medicine
Springer Science and Business Media LLC · based on 15 published papers
Top 2%
8.5× avg
29
Journal of Translational Medicine
Springer Science and Business Media LLC · based on 21 published papers
Top 1%
7.5× avg
30
Journal of Thrombosis and Haemostasis
Elsevier BV · based on 10 published papers
Top 2%
12× avg